<DOC>
	<DOCNO>NCT00532285</DOCNO>
	<brief_summary>This open label phase II single arm trial . The patient clinical stage II III undergo core-needle biopsy breast tumor histologic diagnosis , immunohistochemical study estrogen receptor ( ER ) , progesterone receptor ( PR ) , HER-2/neu others . PET ultrasound result determine positivity lymph node metastasis .</brief_summary>
	<brief_title>Primary Paclitaxel Plus Gemcitabine Patients With Stage II III Breast Cancer</brief_title>
	<detailed_description>Patients treat follow : PG x 4®operation®AC x 4®radiation ± tamoxifen/AI ( postmenopausal ) Intravenous infusion Paclitaxel 80 mg/m2 , 60 min , D1 D8 Followed intravenous infusion Gemcitabine 1200 mg/m2 , 30 min , D1 D8 The cycle repeat every 3 week 4 time . Premedication include antiemetic , dexamethasone , famotidine , pheniramine routinely give . After operation , standard adjuvant chemotherapy ( doxorubicin 60 mg/m2 , cyclophosphamide 600 mg/m2 , every 3 week x 4 cycle ) give .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>All patient must histologically confirm newly diagnose breast cancer : nodepositive stage IIA stage IIB , III . PET result determine node positivity . If PET utilize , sonographically positive node confirm cytologically fine needle aspiration . No prior hormonal , chemotherapy radiotherapy allow . No breast operation biopsy make diagnosis allow . Age : 18years old , pregnant pre , postmenopausal woman good performance status ( ECOG 01 ) Adequate hematopoietic function : Absolute granulocyte count ³1500/mm3 , platelet ³100,000/mm3 , Hemoglobin ³ 10 g/mm3 Adequate renal function : Serum creatinine £ 1.5 mg/dl Adequate hepatic function : total bilirubin : £ 1.5 mg/dl , AST/ALT : £ two time normal , Alkaline phosphatase : £ two time normal Adequate cardiac function : normal nonspecific EKG take within 1 mo enrollment Adequate mental function understand sign consent Patients receive hormonal , chemotherapy radiotherapy breast cancer Patients underwent surgery breast cancer Patients nodenegative stage IIA breast cancer Patients history cancer situ uterine cervix cancer nonmelanotic skin cancer</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>